The Nicotine Series, Finale: A Letter to the Future

Dear reader of the future, if you're reading this in 2035 or 2045 or later—if this series has survived the churn of content and the obsolescence of arguments—you're living in the world we were trying to create. Or the world we were trying to prevent. Or something in between that we couldn't predict. Either way, you know things we didn't. The long-term health effects of vaping, which we could only estimate from biomarkers and mechanistic reasoning, you've measured directly. The population-level impact of nicotine pouches, which we could only model, you've observed. The outcome of the regulatory battles we fought—the PMTA process, the flavor bans, the FCTC COP debates—you've lived through. You know whether we got it right. We didn't.

We didn't know whether the nicotine transition would save millions of lives or create a new epidemic. The evidence pointed strongly toward harm reduction—non-combustible products were dramatically less harmful than cigarettes, and the populations that had access to them were quitting smoking faster. But the long-term evidence wasn't in, and the institutional resistance was formidable. The precautionary principle—'we don't know the long-term effects, so restrict these products'—had genuine force, and the industry's history of deception gave every reason for skepticism. We were making decisions with incomplete evidence, and we knew it. What we didn't always acknowledge was that inaction was also a decision—that every year of delay, every policy that made switching harder, had a mortality cost.

We were divided, and the division shaped the evidence we produced and the policies we enacted. The same studies were interpreted differently by researchers with different institutional commitments. The same data were invoked by both sides of every debate. The polarization was not primarily about the evidence—though we told ourselves it was—but about the values, the institutions, and the histories that the evidence was filtered through. We didn't resolve the polarization. We may have deepened it. If you're living in a world where the nicotine debate has been resolved—where the evidence has converged, the institutions have adapted, and the policies reflect what we now know—you've achieved something we couldn't. We laid the groundwork. You built the structure.

We were particularly concerned about the generations coming after us—the adolescents whose developing brains made them uniquely vulnerable to nicotine, the never-smokers who were initiating nicotine use through products that didn't exist when we were young. We didn't know whether we were protecting them adequately or failing them catastrophically. The policies we implemented—age restrictions, flavor bans, marketing limits—were our best attempt to balance youth protection with adult access. We didn't know if we got the balance right. If you're living with the consequences of our decisions—if you grew up in the world we shaped—you know whether we succeeded or failed. We hope we succeeded. We fear we didn't.

We were motivated, above all, by the scale of the preventable death. Seven million people annually—a number that barely changed during the years we were writing—from a product that could be largely replaced by alternatives that were dramatically less harmful. The gap between what we knew and what we did was the central tragedy of our era. We tried, through these articles and through the advocacy and research and policy work they represented, to close that gap. We didn't close it. We may have narrowed it. If you're living in a world where the gap has been substantially closed—where smoking-related mortality has declined to a fraction of what it was in our time—you've achieved the thing we were striving for.

This series is our record. It's what we knew, what we argued about, what we hoped for, what we failed at. It's incomplete, as all records are. It's biased by our perspectives, our blind spots, the limits of our era's understanding. You'll see things in it that we missed, errors we made, arguments we should have made differently. That's the nature of writing for the future: you know things we didn't, and you'll judge us accordingly. We ask only that you judge us with the same compassion that we tried—imperfectly—to bring to the billion-plus nicotine users whose lives were at the center of every debate and every dispute.

May you have resolved the debates we couldn't. May you have closed the gap between evidence and policy that we documented. May you have reduced the preventable death that haunted our era. And may you, in turn, write your own record for the readers who will come after you—the people who will judge your choices as we hope you judge ours: with honesty about the limits of what was known, and compassion for the difficulty of acting on what was known. The story continues. This is our chapter. The next is yours.